Panel discussion. II: Objectives of basic research and predictive value preclinical testing.
Hoffmeister
F
F
Bayer AG Health Care Sector R & D, Wuppertal.
Assmann
G
G
Born
G V
GV
Bühler
F R
FR
Caspary
W F
WF
Feldmann
R J
RJ
Siegenthaler
W
W
D004353:Drug Evaluation, Preclinical; D004358:Drug Therapy / Q000639:trends*; D010600:Pharmacology / Q000639:trends*; D011237:Predictive Value of Tests; D012106:Research